![Gene Hung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Gene Hung
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Xinthera, Inc.
![]() Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gene Hung tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Conforma Therapeutics Corp.
![]() Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cabrellis Pharmaceuticals Corp.
![]() Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Founder | |
Adimab LLC
![]() Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
Compass Therapeutics LLC
![]() Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Indiana University | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin | |
Prospect Venture Partners
![]() Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
OWENS CORNING | Containers/Packaging | Corporate Officer/Principal | |
Coopers & Lybrand Consulting, Inc. | Corporate Officer/Principal | ||
Foresite Capital Management LLC
![]() Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Hoosier Oncology Group, Inc. | Founder | ||
Seragon Pharmaceuticals, Inc.
![]() Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
ALECTOR, INC. | Biotechnology | Director/Board Member | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member | |
Harvard College | College/University | Undergraduate Degree | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Balance Therapeutics, Inc.
![]() Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member | |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Gemini Therapeutics Sub, Inc.
![]() Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Resolute Therapeutics, Inc.
![]() Resolute Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Resolute Therapeutics, Inc. operates as a biotechnology company. The private company is based in Winston-Salem, NC. | Miscellaneous Commercial Services | Director/Board Member | |
TERNS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Maze Therapeutics, Inc.
![]() Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Emendo Biotherapeutics, Inc.
![]() Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
MBX Biosciences, Inc.
![]() MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Kumquat Biosciences, Inc.
![]() Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Odyssey Therapeutics, Inc.
![]() Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
ADICET BIO, INC. | Pharmaceuticals: Major | Chairman | |
Blossomhill Therapeutics, Inc.
![]() Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Alumis, Inc.
![]() Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. manufactures and sells pharmaceutical products for neuroinflammatory, neurodegenerative, and immune diseases. The company is based in San Francisco, CA. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gwynant Therapeutics
![]() Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
Garuda Therapeutics, Inc.
![]() Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
X4 Pharmaceuticals (Austria) GmbH | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 50 |
Austria | 2 |
Settori
Health Technology | 36 |
Consumer Services | 4 |
Finance | 4 |
Commercial Services | 4 |
Process Industries | 2 |
Posizioni
Director/Board Member | 115 |
Independent Dir/Board Member | 23 |
Corporate Officer/Principal | 20 |
Founder | 18 |
Chief Executive Officer | 13 |
Contatti più connessi
Insiders | |
---|---|
James Tananbaum | 60 |
Carl Gordon | 59 |
Stephen W. Kaldor | 16 |
Chris LeMasters | 15 |
Michael Rome | 6 |
Qing Dong | 2 |
- Borsa valori
- Insiders
- Gene Hung
- Connessioni Società